世界の術中イメージング市場(~2025年):製品別(モバイルCアーム、CT、術中MRI、超音波、X線)、用途別(脳神経外科、整形外科・外傷治療、脊椎、CVD、耳鼻咽喉科、消化器科)、エンドユーザー別(病院、外来手術センター、学術)

◆英語タイトル:Intraoperative Imaging Market by Product (Mobile C-arms, CT, Intraoperative MRI, Ultrasound, X ray), Application (Neurosurgery, Orthopedic & Trauma Care, Spine, CVDs, ENT, Gastroenterology), Enduser (Hospitals, ASCs, Academia)- Forecasts to 2025
◆商品コード:MD3582
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2021年2月26日
◆ページ数:160
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥569,250見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥764,750見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥937,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

マーケッツアンドマーケッツ社は、世界の術中イメージング市場規模が2020年19億ドルから2025年25億ドルまで、年平均5.2%成長すると予測しています。本調査レポートでは、術中イメージングの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(モバイルCアーム、超音波、CT、MRI、X線)分析、用途別(脳神経外科手術、心臓血管手術、整形外科手術、脊椎手術、腫瘍外科手術)分析、エンドユーザー別(病院・診断センター、外来手術センター・診療所、研究所・学術機関)分析、地域別分析、競争状況、企業情報などを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・術中イメージングの世界市場規模:製品別(モバイルCアーム、超音波、CT、MRI、X線)
・術中イメージングの世界市場規模:用途別(脳神経手術、心臓血管手術、整形外科手術、脊椎手術、腫瘍外科手術)
・術中イメージングの世界市場規模:エンドユーザー別(病院・診断センター、外来手術センター・診療所、研究所・学術機関)
・術中イメージングの世界市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The global intraoperative imaging market size is projected to reach USD 2.5 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 5.2%.”
Factors such as the technological advancements in the market are propelling the growth of the intraoperative imaging market. Additionally, rising cases of surgeries, investments from both private and public sectors are having affect in the growth of intraoperative imaging market. However, unfavorable reimbursement scenarios in some countries is hampering the growth of this market.

The recent COVID-19 global pandemic has also impacted the intraoperative imaging market. Demand from the main end-users has declined as key regions and countries have imposed social distancing rules and lockdowns. This impact is expected to be short-term, and no adverse effects are to be foreseen after the market gradually reopens.

“The Mobile C-arms segment to witness the highest growth rate in intraoperative imaging market, by product, during the forecast period.”
Mobile C-arms are medical imaging devices that comprise a generator, the X-ray source, and an image intensifier or flat-panel detector. The growing demand for mobile C-arms is mainly attributed to their broadening application horizons. For instance, C-arms are used for a wide range of applications, including cardiovascular surgeries, neurosurgeries, gastroenterology surgeries, orthopedics, traumatology, and urology disorders.

“The neurosurgery accounted for the largest share of the intraoperative imaging market, by application, in 2020.”
The neurosurgery segment accounted for the largest share of the intraoperative imaging market in 2020. The growing demand for intraoperative imaging solutions in neurosurgery is mainly attributed to the increasing adoption of intraoperative imaging products among medical professionals, owing to its technological advancements and rising awareness of intraoperative techniques. For instance, C-arms with high resolution and penetration are essential in monitoring the positioning of screws, instruments, implants, and the injected cement. Furthermore, 3D imaging with navigation enhances treatment precision and enables the intraoperative evaluation of surgical procedures. The use of C-arms for neurosurgery, especially spinal surgeries, is expected to increase in the coming years on account of technological advancements that have made diagnosing and treating issues easier than before.

“The Hospitals & diagnostic centers segment accounted for the largest share of the intraoperative imaging market, by end users, in 2020”
Hospitals & diagnostic centers accounted for the largest share of the intraoperative imaging market in 2020. The availability of state-of-the-art facilities for treating disorders and injuries and trained personnel has ensured a steady demand for hospital-based care. The inflow of patients is considerably higher in hospitals than in other healthcare settings, which is another key driver for market growth.
Hospitals routinely conduct a wide range of surgical procedures, and most of these surgeries are performed in hospital in-patient settings. Growth in this segment is primarily attributed to the growing number of minimally invasive surgeries and electrosurgery procedures performed in hospitals and the adoption of robotic surgery.

“The Asia Pacific market to grow at the highest CAGR during the forecast period.”
The intraoperative imaging market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Government efforts to increased funding , supportive regulations for the development and commercialization of advanced intraoperative imaging products, rising healthcare expenditure, increasing number of hospitals and clinics in India and China, expanding research base across India, China, and Japan, and the increasing incidence of surgeries are the major factors driving the growth of the APAC intraoperative imaging market.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1: 48%, Tier 2: 36%, and Tier 3: 16%
• By Designation: C-level: 10%, D-level: 14%, and Others: 76%
• By Region: North America: 45%, Europe: 24%, APAC: 20%, Latin America: 7%, and the Middle East & Africa: 4%

The major players operating in the human organoids market are General Electric Company (US), Siemens Healthineers AG (Germany), Ziehm Imaging GmbH (Germany), Medtronic (Ireland), and Koninklijke Philips N.V. (Netherlands) were the top five players in the global intraoperative imaging market. Other notable companies are Canon Healthcare (Japan), Stryker (US), Brainlab AG (Germany), IMRIS (US), Shimadzu Corporation (Japan), Shenzhen Anke High-tech Co. (China), Hitachi, Ltd. (Japan), FUJIFILM Holdings (Japan), Carl Zeiss Meditec AG (Germany), Mindray Ltd. (US), Carestream Health (US), Analogic Corporation (US), Allengers Medical Systems Ltd. (India), Esaote SpA (Italy) and NeuroLogica Corporation (US).

Research Coverage
This report studies the intraoperative imaging market based on the product, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the human organoids market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.2.1 MARKET SCOPE 21
FIGURE 1 MARKETS COVERED 21
1.2.2 GEOGRAPHIC SCOPE 21
1.2.3 YEARS CONSIDERED FOR THE STUDY 22
1.3 CURRENCY USED FOR THE STUDY 22
1.4 MAJOR MARKET STAKEHOLDERS 22
1.5 SUMMARY OF CHANGES 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH DATA 24
FIGURE 2 RESEARCH DESIGN 24
2.1.1 SECONDARY DATA 25
2.1.1.1 Secondary sources 26
2.1.2 PRIMARY DATA 26
FIGURE 3 BREAKDOWN OF PRIMARIES: INTRAOPERATIVE IMAGING MARKET 27
2.2 MARKET ESTIMATION METHODOLOGY 27
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 28
2.2.1 END USER -BASED MARKET ESTIMATION 28
2.2.2 REVENUE MAPPING-BASED MARKET ESTIMATION 29
FIGURE 5 MARKET SIZE ESTIMATION: INTRAOPERATIVE IMAGING MARKET 29
2.2.3 PRIMARY RESEARCH VALIDATION 29
2.3 DATA TRIANGULATION 30
FIGURE 6 DATA TRIANGULATION METHODOLOGY 30
2.4 RESEARCH ASSUMPTIONS 31
2.5 RESEARCH LIMITATIONS 31
3 EXECUTIVE SUMMARY 32
FIGURE 7 INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2020 VS. 2025 (USD MILLION) 32
FIGURE 8 INTRAOPERATIVE IMAGING MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 33
FIGURE 9 INTRAOPERATIVE IMAGING MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 33
FIGURE 10 ASIA PACIFIC MARKET TO GROW AT THE HIGHEST CAGR DURING
THE FORECAST PERIOD 34

4 PREMIUM INSIGHTS 35
4.1 INTRAOPERATIVE IMAGING MARKET OVERVIEW 35
FIGURE 11 INCREASING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH 35
4.2 INTRAOPERATIVE IMAGING MARKET, BY PRODUCT 36
FIGURE 12 MOBILE C-ARMS TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD 36
4.3 APAC: INTRAOPERATIVE IMAGING MARKET, BY COUNTRY AND PRODUCT 37
FIGURE 13 JAPAN IS THE LARGEST MARKET FOR INTRAOPERATIVE IMAGING IN APAC 37
4.4 INTRAOPERATIVE IMAGING MARKET SHARE, BY END USER 38
FIGURE 14 HOSPITALS & DIAGNOSTIC CENTERS TO ACCOUNT FOR THE LARGEST MARKET SHARE DURING THE FORECAST PERIOD 38
4.5 GEOGRAPHICAL SNAPSHOT OF THE INTRAOPERATIVE IMAGING MARKET 38
FIGURE 15 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 38
5 MARKET OVERVIEW 39
5.1 INTRODUCTION 39
5.2 MARKET DYNAMICS 39
FIGURE 16 INTRAOPERATIVE IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 39
5.2.1 DRIVERS 40
5.2.1.1 Rising geriatric population and growth in the prevalence of chronic diseases 40
TABLE 1 AGE-RELATED DISEASES: PREVALENCE AND ESTIMATIONS 40
5.2.1.2 Technological advancements in intraoperative imaging modalities 40
5.2.1.3 Increasing demand for minimally invasive surgeries 41
5.2.1.4 Rising investments/funds/grants by public-private organizations 41
TABLE 2 KEY INVESTMENTS BY GOVERNMENT BODIES IN THE INTRAOPERATIVE IMAGING MARKET 41
5.2.2 RESTRAINTS 42
5.2.2.1 High cost of intraoperative imaging systems 42
5.2.2.2 Declining reimbursements and increasing regulatory burden 42
5.2.3 OPPORTUNITIES 43
5.2.3.1 High growth opportunities in emerging countries 43
5.2.3.2 Adoption of AI and analytics in intraoperative imaging 43
5.2.4 CHALLENGES 44
5.2.4.1 Hospital budget cuts 44
5.2.4.2 Dearth of trained professionals 44
5.2.4.3 Increasing adoption of refurbished systems 44
5.3 REGULATORY SCENARIO 45
5.4 ECOSYSTEM COVERAGE 47
5.5 VALUE CHAIN ANALYSIS 47
5.6 PRICING ANALYSIS 48
TABLE 3 INTRAOPERATIVE IMAGING PRODUCTS PRICING ANALYSIS (USD, 2019) 48
5.7 PORTER’S 5 FORCE ANALYSIS 48
6 INTRAOPERATIVE IMAGING MARKET, BY PRODUCT 49
6.1 INTRODUCTION 50
TABLE 4 INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 50
6.2 MOBILE C-ARMS 50
6.2.1 MULTI-FUNCTIONAL CAPABILITIES OF C-ARMS WILL INCREASE THEIR ADOPTION AMONG SURGEONS 50
TABLE 5 PRODUCT HIGHLIGHTS 51
TABLE 6 INTRAOPERATIVE IMAGING MARKET FOR MOBILE C-ARMS, BY REGION, 2018–2025 (USD MILLION) 51
TABLE 7 INTRAOPERATIVE IMAGING MARKET FOR MOBILE C-ARMS, BY APPLICATION, 2018–2025 (USD MILLION) 52
TABLE 8 INTRAOPERATIVE IMAGING MARKET FOR MOBILE C-ARMS, BY END USER, 2018–2025 (USD MILLION) 52
6.3 ULTRASOUND SYSTEMS 53
6.3.1 DIAGNOSTIC SUPERIORITY AND GROWING APPLICATIONS WILL INCREASE THE ADOPTION OF INTRAOPERATIVE ULTRASOUND 53
TABLE 9 INTRAOPERATIVE IMAGING MARKET FOR ULTRASOUND SYSTEMS,
BY PRODUCT, 2018–2025 (USD MILLION) 53
TABLE 10 INTRAOPERATIVE IMAGING MARKET FOR ULTRASOUND SYSTEMS,
BY REGION, 2018–2025 (USD MILLION) 54
TABLE 11 INTRAOPERATIVE IMAGING MARKET FOR ULTRASOUND SYSTEMS,
BY APPLICATION, 2018–2025 (USD MILLION) 54
TABLE 12 INTRAOPERATIVE IMAGING MARKET FOR ULTRASOUND SYSTEMS,
BY END USER, 2018–2025 (USD MILLION) 55
6.3.2 DROP IN PROBES 55
6.3.2.1 Drop in Probes segment will dominate the ultrasound market in upcoming years 55
TABLE 13 INTRAOPERATIVE IMAGING MARKET FOR DROP IN PROBES, BY REGION, 2018–2025 (USD MILLION) 56
6.3.3 LAPAROSCOPIC PROBES 56
6.3.3.1 Laparoscopic probe utilization is augmented by rising number of related surgical procedures across key geographies. 56
TABLE 14 INTRAOPERATIVE IMAGING MARKET FOR LAPAROSCOPIC PROBES,
BY REGION, 2018–2025 (USD MILLION) 56
6.3.4 OTHER ULTRASOUND SYSTEMS 57
6.3.4.1 Other ultrasound segment market will have smaller segment due to technical difficulties. 57
TABLE 15 INTRAOPERATIVE IMAGING MARKET FOR OTHER ULTRASOUND SYSTEMS,
BY REGION, 2018–2025 (USD MILLION) 57
6.4 CT SCANNERS 57
6.4.1 CT USE IN DIAGNOSTIC APPLICATIONS HAS RISEN SIGNIFICANTLY IN RECENT YEARS 57
TABLE 16 INTRAOPERATIVE IMAGING MARKET FOR CT SCANNERS, BY REGION,
2018–2025 (USD MILLION) 58
TABLE 17 INTRAOPERATIVE IMAGING MARKET FOR CT SCANNERS, BY APPLICATION, 2018–2025 (USD MILLION) 58
TABLE 18 INTRAOPERATIVE IMAGING MARKET FOR CT SCANNERS, BY END USER, 2018–2025 (USD MILLION) 59
6.5 MRI SCANNERS 59
6.5.1 FASTER SCAN TIMES AND INCREASED IMAGE QUALITY TO INCREASE
THE ADOPTION OF INTRAOPERATIVE MRI SYSTEMS 59
TABLE 19 INTRAOPERATIVE IMAGING MARKET FOR MRI SCANNERS, BY REGION, 2018–2025 (USD MILLION) 60
TABLE 20 INTRAOPERATIVE IMAGING MARKET FOR MRI SCANNERS, BY APPLICATION, 2018–2025 (USD MILLION) 60
TABLE 21 INTRAOPERATIVE IMAGING MARKET FOR MRI SCANNERS, BY END USER, 2018–2025 (USD MILLION) 61
6.6 X-RAY SYSTEMS 61
6.6.1 POSSIBILITY OF SIDE-EFFECTS DUE TO RADIATION EXPOSURE MAY HINDER MARKET GROWTH 61
TABLE 22 INTRAOPERATIVE IMAGING MARKET FOR X-RAY SYSTEMS, BY REGION, 2018–2025 (USD MILLION) 61
TABLE 23 INTRAOPERATIVE IMAGING MARKET FOR X-RAY SYSTEMS, BY APPLICATION, 2018–2025 (USD MILLION) 62
TABLE 24 INTRAOPERATIVE IMAGING MARKET FOR X-RAY SYSTEMS, BY END USER, 2018–2025 (USD MILLION) 62
6.7 OPTICAL IMAGING SYSTEMS 63
6.7.1 GROWING DEMAND FOR NON-IONIZING IMAGING MODALITIES TO AID MARKET GROWTH 63
TABLE 25 INTRAOPERATIVE IMAGING MARKET FOR OPTICAL IMAGING SYSTEMS,
BY REGION, 2018–2025 (USD MILLION) 63
TABLE 26 INTRAOPERATIVE IMAGING MARKET FOR OPTICAL IMAGING SYSTEMS,
BY APPLICATION, 2018–2025 (USD MILLION) 64
TABLE 27 INTRAOPERATIVE IMAGING MARKET FOR OPTICAL IMAGING SYSTEMS,
BY END USER, 2018–2025 (USD MILLION) 64
7 INTRAOPERATIVE IMAGING MARKET, BY APPLICATION 65
7.1 INTRODUCTION 66
TABLE 28 INTRAOPERATIVE IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 66
7.2 NEUROSURGERY 66
7.2.1 NEUROSURGERY HOLDS THE LARGEST SHARE OF THE APPLICATIONS MARKET 66
TABLE 29 INTRAOPERATIVE IMAGING MARKET FOR NEUROSURGERY, BY REGION, 2018–2025 (USD MILLION) 67
7.3 CARDIOVASCULAR SURGERY 67
7.3.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO SUPPORT THE MARKET GROWTH 67
TABLE 30 INTRAOPERATIVE IMAGING MARKET FOR CARDIOVASCULAR SURGERY,
BY REGION, 2018–2025 (USD MILLION) 68

7.4 ORTHOPEDIC SURGERY 68
7.4.1 RISING GERIATRIC POPULATION & RISING OBESITY RATES HAVE DRIVEN
THE NUMBER OF ORTHOPEDIC SURGERIES PERFORMED 68
TABLE 31 INTRAOPERATIVE IMAGING MARKET FOR ORTHOPEDIC SURGERY,
BY REGION, 2018–2025 (USD MILLION) 69
7.5 SPINE SURGERY 69
7.5.1 RISING NUMBER OF SPINE INJURIES AND GROWING ACCESS TO SPINE SURGERY WILL DRIVE MARKET GROWTH 69
TABLE 32 INTRAOPERATIVE IMAGING MARKET FOR SPINE SURGERY, BY REGION, 2018–2025 (USD MILLION) 70
7.6 SURGICAL ONCOLOGY 70
7.6.1 INCREASING PREVALENCE OF CANCER WILL DRIVE THE MARKET GROWTH 70
TABLE 33 INTRAOPERATIVE IMAGING MARKET FOR SURGICAL ONCOLOGY, BY REGION, 2018–2025 (USD MILLION) 71
7.7 EMERGENCY AND TRAUMA SURGERIES 71
7.7.1 EMERGENCY & TRAUMA CENTERS SUPPORTS THE GORWTH OF THIS SEGMENTS 71
TABLE 34 INTRAOPERATIVE IMAGING MARKET FOR EMERGENCY SURGERIES,
BY REGION, 2018–2025 (USD MILLION) 72
7.8 ENT SURGERY 72
7.8.1 GROWING FOCUS ON MINIMALLY INVASIVE AND IMAGE-GUIDED SURGERY SHOWCASE STRONG GROWTH POTENTIAL 72
TABLE 35 INTRAOPERATIVE IMAGING MARKET FOR ENT SURGERY, BY REGION,
2018–2025 (USD MILLION) 73
7.9 UROLOGICAL SURGERY 73
7.9.1 GROWING INCIDENCE OF UROLOGICAL CONDITIONS TO AUGMENT POSITIVE GROWTH POTENTIAL OF RELATED SURGICAL PLATFORMS 73
TABLE 36 INTRAOPERATIVE IMAGING MARKET FOR UROLOGICAL SURGERY,
BY REGION, 2018–2025 (USD MILLION) 74
7.10 HBP (HEPATO-PANCREATICO-BILIARY) SURGERY 74
7.10.1 GROWING INCIDENCE OF UROLOGICAL SURGERY CONDISTIONS SHOWCASE STRONG GROWTH POTENTIAL 74
TABLE 37 INTRAOPERATIVE IMAGING MARKET FOR HPB SURGERY, BY REGION,
2018–2025 (USD MILLION) 75
7.11 COLORECTAL SURGERIES 76
7.11.1 COLORECTAL SEGMENT IS LIKELY TO GROW AT SLOW GROWTH RATE IN UPCOMING YEAR 76
TABLE 38 INTRAOPERATIVE IMAGING MARKET FOR COLORECTAL SURGERIES,
BY REGION, 2018–2025 (USD MILLION) 76
7.12 GENERAL SURGERY 76
7.12.1 INCREASING NUMBER OF BARIATRIC SURGERY TO DRIVE MARKET GROWTH 76
TABLE 39 INTRAOPERATIVE IMAGING MARKET FOR GENERAL SURGERIES, BY REGION, 2018–2025 (USD MILLION) 77
7.13 OTHER APPLICATIONS 77
7.13.1 OTHER APPLICATIONS SEGMENT IS LIKELY TO GROW AT SLOW GROWTH RATE IN UPCOMING YEAR 77
TABLE 40 INTRAOPERATIVE IMAGING MARKET FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 78
8 INTRAOPERATIVE IMAGING MARKET, BY END USER 79
8.1 INTRODUCTION 80
TABLE 41 INTRAOPERATIVE IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 80
8.2 HOSPITALS & DIAGNOSTIC CENTERS 80
8.2.1 INCREASING NUMBER OF SURGERIES AND HIGH PURCHASING POWER TO SUPPORT THE GROWTH OF THIS SEGMENT 80
TABLE 42 INTRAOPERATIVE IMAGING MARKET FOR HOSPITALS & DIAGNOSTICS CENTERS, BY REGION, 2018–2025 (USD MILLION) 81
8.3 AMBULATORY SURGICAL CENTERS & CLINICS 81
8.3.1 INCREASING NUMBER OF ASCS LIKELY TO DRIVE MARKET GROWTH 81
TABLE 43 INTRAOPERATIVE IMAGING MARKET FOR AMBULATORY SURGICAL CENTERS & CLINICS, BY REGION, 2018–2025 (USD MILLION) 82
8.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES 82
8.4.1 BUDGETARY RESTRICTIONS OF RESEARCHERS ARE LIMITING THE ADOPTION OF HIGH-END INTRAOPERATIVE IMAGING PRODUCTS 82
TABLE 44 INTRAOPERATIVE IMAGING MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018–2025 (USD MILLION) 83
9 INTRAOPERATIVE IMAGING MARKET, BY REGION 84
9.1 INTRODUCTION 85
TABLE 45 INTRAOPERATIVE IMAGING MARKET, BY REGION, 2018–2025 (USD MILLION) 85
9.2 NORTH AMERICA 86
FIGURE 17 NORTH AMERICA: INTRAOPERATIVE IMAGING MARKET SNAPSHOT 86
TABLE 46 NORTH AMERICA: INTRAOPERATIVE IMAGING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 87
TABLE 47 NORTH AMERICA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 87
TABLE 48 NORTH AMERICA: INTRAOPERATIVE IMAGING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 88
TABLE 49 NORTH AMERICA: INTRAOPERATIVE IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 88
9.2.1 US 89
9.2.1.1 The US dominates the North American market 89
TABLE 50 INCREASE IN TARGET POPULATION/DISEASE PREVALENCE IN THE US 89
TABLE 51 US: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 90
9.2.2 CANADA 90
9.2.2.1 A dearth of radiologists and long waiting times restrain market growth in Canada 90
TABLE 52 INCREASE IN TARGET POPULATION/DISEASE PREVALENCE IN CANADA 90
TABLE 53 CANADA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 91
9.3 EUROPE 91
TABLE 54 EUROPE: INTRAOPERATIVE IMAGING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 92
TABLE 55 EUROPE: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 92
TABLE 56 EUROPE: INTRAOPERATIVE IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 93
TABLE 57 EUROPE: INTRAOPERATIVE IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 93
9.3.1 GERMANY 94
9.3.1.1 Germany holds the largest share of the market in Europe 94
TABLE 58 INCREASE IN TARGET POPULATION/DISEASE PREVALENCE IN GERMANY 94
TABLE 59 GERMANY: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 94
9.3.2 UK 95
9.3.2.1 Government initiatives to support market growth in the UK 95
TABLE 60 UK: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 95
9.3.3 FRANCE 96
9.3.3.1 Availability of funding, strong player presence, and government support are key drivers in France 96
TABLE 61 FRANCE: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 96
9.3.4 ITALY 97
9.3.4.1 Favorable regulatory policies likely to support market growth 97
TABLE 62 ITALY: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 97
9.3.5 SPAIN 98
9.3.5.1 Preference for new equipment likely to increase the market growth 98
TABLE 63 SPAIN: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 98
9.3.6 REST OF EUROPE 98
TABLE 64 ROE: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 99
9.4 ASIA PACIFIC 100
FIGURE 18 ASIA PACIFIC: INTRAOPERATIVE IMAGING MARKET SNAPSHOT 100
TABLE 65 APAC: INTRAOPERATIVE IMAGING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 101
TABLE 66 APAC: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 101
TABLE 67 APAC: INTRAOPERATIVE IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 102
TABLE 68 APAC: INTRAOPERATIVE IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 102
9.4.1 JAPAN 103
9.4.1.1 Japan dominates the APAC market 103
TABLE 69 JAPAN: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 104
9.4.2 CHINA 104
9.4.2.1 Government initiatives and investments support the growth of the Chinese market 104
TABLE 70 CHINA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 105
9.4.3 INDIA 105
9.4.3.1 Rising disease incidence and growing awareness support market growth; uncertainties in healthcare policies and uneven coverage pose challenges 105
TABLE 71 INDIA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 106
9.4.4 AUSTRALIA 106
9.4.4.1 Support for R&D and equipment purchases drives the market growth in Australia 106
TABLE 72 AUSTRALIA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 107
9.4.5 SOUTH KOREA 107
9.4.5.1 Supportive government initiatives expected to impact market growth positively 107
TABLE 73 SOUTH KOREA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 108
9.4.6 REST OF ASIA PACIFIC 108
TABLE 74 ROAPAC: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 109
9.5 LATIN AMERICA 109
TABLE 75 LATIN AMERICA: INTRAOPERATIVE IMAGING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 110
TABLE 76 LATAM: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 110
TABLE 77 LATAM: INTRAOPERATIVE IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 111
TABLE 78 LATAM: INTRAOPERATIVE IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 111
9.5.1 BRAZIL 112
9.5.1.1 Growing disease burden and rising awareness to support market growth in Brazil 112
TABLE 79 BRAZIL: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 112
9.5.2 MEXICO 113
9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth in Mexico 113
TABLE 80 MEXICO: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 113
9.5.3 REST OF LATIN AMERICA 114
TABLE 81 ROLATAM: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 114
9.6 MIDDLE EAST AND AFRICA 115
9.6.1 RISING DISPOSABLE INCOME AND INFRASTRUCTURAL DEVELOPMENT TO CONTRIBUTE TO MARKET GROWTH 115
TABLE 82 MEA: INTRAOPERATIVE IMAGING MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 115
TABLE 83 MEA: INTRAOPERATIVE IMAGING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 116
TABLE 84 MEA: INTRAOPERATIVE IMAGING MARKET, BY END USER,
2018–2025 (USD MILLION) 116
10 COMPETITIVE LANDSCAPE 117
10.1 OVERVIEW 117
FIGURE 19 KEY DEVELOPMENTS IN THE INTRAOPERATIVE IMAGING MARKET
(2017–2020) 117
10.2 GLOBAL MARKET SHARE ANALYSIS (2019) 118
FIGURE 20 GE HEALTHCARE HELD THE LEADING POSITION IN THE INTRAOPERATIVE IMAGING MARKET IN 2019 118
10.3 COMPETITIVE SCENARIO (2017–2020) 119
10.3.1 KEY PRODUCT LAUNCHES (2017–2020) 119
10.3.2 KEY EXPANSIONS (2017–2020) 119
10.3.3 KEY ACQUISITIONS (2017–2020) 120
10.3.4 KEY AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS (2017–2020) 120
10.4 COMPETITIVE LEADERSHIP MAPPING 121
10.5 VENDOR INCLUSION CRITERIA 121
10.5.1 STARS 121
10.5.2 EMERGING LEADERS 122
10.5.3 PERVASIVE PLAYERS 122
10.5.4 PARTICIPANTS 122
FIGURE 21 INTRAOPERATIVE IMAGING MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019 123
10.6 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS (2019) 124
10.6.1 PROGRESSIVE COMPANIES 124
10.6.2 STARTING BLOCKS 124
10.6.3 RESPONSIVE COMPANIES 124
10.6.4 DYNAMIC COMPANIES 124
FIGURE 22 INTRAOPERATIVE IMAGING MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2019 (SME/START-UPS) 125
11 COMPANY PROFILES 126
(Business overview, Products offered, Recent developments, MNM view)*
11.1 GENERAL ELECTRIC COMPANY 126
FIGURE 23 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT 126
11.2 SIEMENS HEALTHINEERS AG 128
FIGURE 24 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT 128
11.3 CANON MEDICAL SYSTEMS CORPORATION 131
FIGURE 25 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT 131
11.4 MEDTRONIC PLC 135
FIGURE 26 MEDTRONIC PLC: COMPANY SNAPSHOT (2019) 135
11.5 KONINKLIJKE PHILIPS N.V. 137
FIGURE 27 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 137
11.6 CARESTREAM HEALTH 139
11.7 SHIMADZU CORPORATION 140
FIGURE 28 SHIMADZU CORPORATION: COMPANY SNAPSHOT 140
11.8 SHENZHEN ANKE HIGH-TECH CO., LTD. 142
11.9 BRAINLAB AG 143
11.10 ZIEHM IMAGING GMBH 144
11.11 HITACHI, LTD. 145
FIGURE 29 HITACHI, LTD.: COMPANY SNAPSHOT 145
11.12 FUJIFILM HOLDINGS CORPORATION 147
FIGURE 30 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT 147
11.13 IMRIS, DEERFIELD IMAGING, INC. 149
11.14 STRYKER CORPORATION 150
FIGURE 31 STRYKER CORPORATION: COMPANY SNAPSHOT (2019) 150
11.15 NEUROLOGICA CORPORATION 152
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
11.16 OTHER COMPANIES 153
11.16.1 ESAOTE SPA 153
11.16.2 ANALOGIC CORPORATION 154
11.16.3 MINDRAY MEDICAL INTERNATIONAL LIMITED 154
11.16.4 CARL ZEISS MEDITEC AG 155
11.16.5 ALLENGERS MEDICAL SYSTEMS LTD. 155
12 APPENDIX 156
12.1 DISCUSSION GUIDE 156
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 160
12.3 AVAILABLE CUSTOMIZATIONS 162
12.4 RELATED REPORTS 162
12.5 AUTHOR DETAILS 163



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の術中イメージング市場(~2025年):製品別(モバイルCアーム、CT、術中MRI、超音波、X線)、用途別(脳神経外科、整形外科・外傷治療、脊椎、CVD、耳鼻咽喉科、消化器科)、エンドユーザー別(病院、外来手術センター、学術)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆